Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Oncology
US Oncology, Inc. Announces Issuance of $775 Million of Debt Securities
July 5th, 2009
US Oncology, Inc. (the "Company") announced that it has issued an aggregate $775 million principal amount of 9.125% senior secured notes due 2017. The notes will be senior secured obligations of the Company. Proceeds of the notes were used to repay $436.7 million outstanding under the term loan portion of the Company's existing senior secured credit facility (which was scheduled to mature in quarterly installments from September 2010 through August 2011) and to discharge $300.0 million outstanding 9% Senior Notes due 2012 (the "existing Senior Notes"), as well as to pay fees and expenses relating to the offering. The existing Senior Notes will be redeemed on August 17, 2009 at a redemption...
Source: Pharma Investments, Ventures & Law Weekly (2009-07-05)
|
